P641 Ustekinumab efficiency as a higher-line therapy in association with serum levels in patients with Crohn’s disease

Autor:	M Kolar, K Pudilova, M Bortlik, D Duricova, K Malickova, M Lukas, V Hruba, N Machkova, R Vanickova, K Mitrova, M Vasatko
Rok vydání:	2019
Předmět:	medicine.medical_specialty Crohn's disease business.industry Gastroenterology General Medicine medicine.disease Internal medicine Ustekinumab medicine In patient Line (text file) business medicine.drug
Zdroj:	Journal of Crohn's and Colitis. 13:S438-S439
ISSN:	1876-4479 1873-9946
DOI:	10.1093/ecco-jcc/jjy222.765
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::68acd5046789db0587a384d762a5dec9 https://doi.org/10.1093/ecco-jcc/jjy222.765 Zobrazit plný text záznamu